Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice

Journal of General Virology

Volumn 87, Issue 7, 2006, Pages 2005-2009

  Boyd, Amanda ^a,c   Fazakerley, John K ^a   Bridgen, Anne ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; CASPASE 3; INTERFERON; PROTEIN KINASE R; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFECTION; BRAIN NERVE CELL; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DUGBE VIRUS; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; INOCULATION; MOUSE; NAIRO VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE;

ANIMALS; BRAIN; BUNYAVIRIDAE INFECTIONS; EIF-2 KINASE; GTP-BINDING PROTEINS; HUMANS; INJECTIONS; INJECTIONS, INTRAPERITONEAL; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NAIROVIRUS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; VIRULENCE;

DUGBE VIRUS; NAIROVIRUS;

EID: 33745629581     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81767-0     Document Type: Article

References (40)

1. Andersson, I., Bladh, L., Mousavi-Jazi, M., Magnusson, K.-E., Lundkvist, Å., Haller, O. & Mirazimi, A. (2004). Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 78, 4323-4329.
2. Andersson, I., Lundkvist, Å., Haller, O. & Mirazimi, A. (2006). Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 78, 216-222.
3. Blakqori, G. & Weber, F. (2005). Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol 79, 10420-10428.
4. Bridgen, A., Dalrymple, D. A. & Elliott, R. M. (2002). Dugbe nairovirus S segment: correction of the sequence and comparison of five isolates. Virology 294, 364-371.
5. Bridgen, A., Dalrymple, D. A., Weber, F. & Elliott, R. M. (2004). Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res 99, 47-50.
6. Buckley, A., Higgs, S. & Gould, E. A. (1990). Dugbe virus susceptibility to neutralization by monoclonal antibodies as a marker of virulence in mice. Arch Virol, Supplementum 1, 197-205.
7. Burt, F. J. & Swanepoel, R. (2005). Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates. Epidemiol Infect 133, 659-666.
8. Burt, F. J., Spencer, D. C., Leman, P. A., Patterson, B. & Swanepoel, R. (1996). Investigation of tick-borne viruses as pathogens of humans in South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia. Epidemiol Infect 116, 353-361.
9. Coates, D. M. & Sweet, C. (1990). Studies on the pathogenicity of a nairovirus, Dugbe virus, in normal and immunosuppressed mice. J Gen Virol 71, 325-332.
10. Colón-Ramos, D. A., Irusta, P. M., Gan, E. C. & 9 other authors (2003). Inhibition of translation and induction of apoptosis by bunyaviral nonstructural proteins bearing sequence similarity to reaper. Mol Biol Cell 14, 4162-4172.
11. David-West, T. S. & Porterfield, J. S. (1974). Dugbe virus: a tick-borne arbovirus from Nigeria. J Gen Virol 23, 297-307.
12. Elliott, R. M., Bouloy, M., Calisher, C. H., Goldbach, R., Moyer, J. T., Nichol, S. T., Pettersson, R., Plyusnin, A. & Schmaljohn, C. S. (2000). Bunyaviridae. In Virus Taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses, pp. 599-621. Edited by M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle & R. B. Wickner. San Diego: Academic Press.
13. Frese, M., Kochs, G., Feldmann, H., Hertkorn, C. & Haller, O. (1996). Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol 70, 915-923.
14. Gonzalez, J. P., Wilson, M. L., Cornet, J. P. & Camicas, J. L. (1995). Host-passage-induced phenotypic changes in Crimean-Congo haemorrhagic fever virus. Res Virol 146, 131-140.
15. Haller, O., Frese, M. & Kochs, G. (1998). Mx proteins: mediators of innate resistance to RNA viruses. Rev Sci Tech 17, 220-230.
16. Hardestam, J., Klingström, J., Mattsson, K. & Lundkvist, Å. (2005). HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells. J Med Virol 76, 234-240.
17. Hefti, H. P., Frese, M., Landis, H., Di Paolo, C., Aguzzi, A., Haller, O. & Pavlovic, J. (1999). Human MxA protein protects mice lacking a functional alpha/beta interferon system against La Crosse virus and other lethal viral infections. J Virol 73, 6984-6991.
18. Hoogstraal, H. (1979). The epidemiology of tick-borne Crimean-Congo haemorrhagic fever in Asia, Europe and Africa. J Med Entomol 15, 307-417.
19. Khaiboullina, S. F., Rizvanov, A. A., Otteson, E., Miyazato, A., Maciejewski, J. & St Jeor, S. (2004). Regulation of cellular gene expression in endothelial cells by Sin Nombre and Prospect Hill viruses. Viral Immunol 17, 234-251.
20. Kochs, G., Janzen, C., Hohenberg, H. & Haller, O. (2002). Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci U S A 99, 3153-3158.
21. Kohl, A., Clayton, R. F., Weber, F., Bridgen, A., Randall, R. E. & Elliott, R. M. (2003). Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol 77, 7999-8008.
22. Li, X.-D., Kukkonen, S., Vapalahti, O., Plyusnin, A., Lankinen, H. & Vaheri, A. (2004). Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J Gen Virol 85, 3261-3268.
23. Marriott, A. C. & Nuttall, P. A. (1996). Molecular biology of nairoviruses. In The Bunyaviridae, pp. 91-104. Edited by R. M. Elliott. New York: Plenum.
24. Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. & Aguet, M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
25. Nam, J.-H., Hwang, K.-A., Yu, C.-H. & 7 other authors (2003). Expression of interferon inducible genes following Hantaan virus infection as a mechanism of resistance in A549 cells. Virus Genes 26, 31-38.
26. Papa, A., Ma, B., Kouidou, S., Tang, Q., Hang, C. & Antoniadis, A. (2002). Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China. Emerg Infect Dis 8, 50-53.
27. Pavlovic, J., Arzet, H. A., Hefti, H. P., Frese, M., Rost, D., Ernst, B., Kolb, E., Staeheli, P. & Haller, O. (1995). Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol 69, 4506-4510.
28. Pekosz, A., Phillips, J., Pleasure, D., Merry, D. & Gonzalez-Scarano, F. (1996). Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol 70, 5329-5335.
29. Sanchez, A. J., Vincent, M. J. & Nichol, S. T. (2002). Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J Virol 76, 7263-7275.
30. Sanchez, A. J., Vincent, M. J., Erickson, B. R. & Nichol, S. T. (2006). Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J Virol 80, 514-525.
31. Silverman, R. H. (1994). Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J Interferon Res 14, 101-104.
32. Smirnova, S. E., Shestopalova, N. M., Reingold, V. N., Zubri, G. L. & Chumakov, M. P. (1977). Experimental Hazara virus infection in mice. Acta Virol 21, 128-132.
33. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. (1998). How cells respond to interferons. Annu Rev Biochem 67, 227-264.
34. Streitenfeld, H., Boyd, A., Fazakerley, J. K., Bridgen, A., Elliott, R. M. & Weber, F. (2003). Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J Virol 77, 5507-5511.
35. Swanepoel, R., Shepherd, A. J., Leman, P. A., Shepherd, S. P., McGillivray, G. M., Erasmus, M. J., Searle, L. A. & Gill, D. E. (1987). Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg 36, 120-132.
36. Tignor, G. H. & Hanham, C. A. (1993). Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res 22, 309-325.
37. Watret, G. E., Pringle, C. R. & Elliott, R. M. (1985). Synthesis of bunyavirus-specific proteins in a continuous cell line (XTC-2) derived from Xenopus laevis. J Gen Virol 66, 473-482.
38. Whitehouse, C. A. (2004). Crimean-Congo hemorrhagic fever. Antiviral Res 64, 145-160.
39. Williams, B. R. (1999). PKR; a sentinel kinase for cellular stress. Oncogene 18, 6112-6120.
40. Yang, Y.-L., Reis, L. F. L., Pavlovic, J., Aguzzi, A., Schäfer, R., Kumar, A., Williams, B. R. G., Aguet, M. & Weissmann, C. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 24, 6095-6106.